Amkay Products Ltd vs Vanta Bioscience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 26, 2026

Key Highlights

The Latest Trading Price of Amkay Products Ltd is ₹ 53.5 as of 23 Oct 15:30 . The P/E Ratio of Amkay Products Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Vanta Bioscience Ltd changed from 229.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Amkay Products Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Vanta Bioscience Ltd changed from ₹ 102.89 crore on March 2021 to ₹ 13.96 crore on March 2025 . This represents a CAGR of -32.93% over 5 years The Dividend Payout of Amkay Products Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Vanta Bioscience Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Amkay Products Ltd

Amkay Products Limited was originally incorporated as 'Amkay Products Private Limited' on October 25, 2007 with the Registrar of Companies, Mumbai.
Subsequently, the Company was converted into a Public Limited Company and the name was changed from 'Amkay Products Private Limited' to 'Amkay Products Limited' vide a fresh Certificate of Incorporation dated August 28, 2023, issued by the Registrar of Companies, Maharashtra, Mumbai. The Company manufacture, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Steel/ Plastic Lancet Needles, Air Bed, Apron, Digital Thermometer, Nebulizer, Shoe Cover, BP Monitor, Pulse Oximeter, Surgeon Cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. widely spread across India.

About Vanta Bioscience Ltd

Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017. VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.
It also provides expert services for determination of health based exposure limits (e.

FAQs for the comparison of Amkay Products Ltd and Vanta Bioscience Ltd

Which company has a larger market capitalization, Amkay Products Ltd or Vanta Bioscience Ltd?

Market cap of Amkay Products Ltd is 46 Cr while Market cap of Vanta Bioscience Ltd is 14 Cr

What are the key factors driving the stock performance of Amkay Products Ltd and Vanta Bioscience Ltd?

The stock performance of Amkay Products Ltd and Vanta Bioscience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amkay Products Ltd and Vanta Bioscience Ltd?

As of October 26, 2026, the Amkay Products Ltd stock price is INR ₹53.5. On the other hand, Vanta Bioscience Ltd stock price is INR ₹20.4.

How do dividend payouts of Amkay Products Ltd and Vanta Bioscience Ltd compare?

To compare the dividend payouts of Amkay Products Ltd and Vanta Bioscience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.